Sign in

CIK 0001759425

  • Large accelerated filer

Mirum Pharmaceuticals, Inc.

Sign in to watch
Ticker
MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831281555
Phone
+1 650-667-4085
Business address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,138,950
in 5 filings, $4.8M under 10b5-1 plans

Net −$7,138,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-31 Longpre Lara Chief Development Officer Grant or award · Stock Option (right to buy) +38,500 38,500
2023-01-31 Vig Pamela Head of Research & Development Grant or award +9,625 31,527
2023-01-31 Vig Pamela Head of Research & Development Grant or award · Stock Option (right to buy) +38,500 38,500
2023-01-31 Radovich Peter Chief Operating Officer Grant or award +14,440 38,132
2023-01-31 Radovich Peter Chief Operating Officer Grant or award · Stock Option (right to buy) +57,750 57,750
2023-01-09 Radovich Peter PRESIDENT AND COO Sale −1,379 $20.62 $28K 33,316
2023-01-09 Vig Pamela CHIEF SCIENTIFIC OFFICER Sale −1,379 $20.62 $28K 27,312
2023-01-09 Longpre Lara CHIEF DEVELOPMENT OFFICER Sale −1,003 $20.62 $21K 104,369
2023-01-09 Peetz Christopher CHIEF EXECUTIVE OFFICER Sale −5,159 $20.62 $106K 91,953
2019-09-10 Longpre Lara CHIEF DEVELOPMENT OFFICER Purchase +965 $10.64 $10K 105,372

Page 25 of 25 · 490 trades